Albert Moghrabi Selected Research

Albert Moghrabi Research Topics

Disease

21	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2013 - 01/2002
19	Neoplasms (Cancer) 07/2011 - 01/2002
6	Medulloblastoma 01/2017 - 06/2003
5	Leukemia 05/2013 - 03/2002
4	Disease Progression 09/2010 - 07/2002
4	Brain Neoplasms (Brain Tumor) 09/2010 - 06/2003
2	Thrombosis (Thrombus) 07/2010 - 10/2007
2	Infections 11/2009 - 03/2008
2	Cardiotoxicity 03/2008 - 03/2002
2	Hypersensitivity (Allergy) 10/2007 - 03/2007
2	Glioma (Gliomas) 08/2005 - 07/2002
1	Adenocarcinoma 12/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2023
1	Astrocytoma (Pilocytic Astrocytoma) 08/2015
1	Pain (Aches) 05/2013
1	Osteonecrosis (Kienbock's Disease) 05/2013
1	Cardiomyopathies (Cardiomyopathy) 10/2010
1	Brain Stem Neoplasms (Brain Stem Tumor) 09/2010
1	Neoplasm Metastasis (Metastasis) 12/2009
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 12/2009
1	Choroid Plexus Papilloma 12/2009
1	Neutropenia 11/2009
1	Ototoxicity 07/2009
1	Choroid Plexus Carcinoma 07/2009
1	Ependymoma 07/2009
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2009
1	Rhabdoid Tumor (Rhabdoid Tumors) 07/2009
1	Carcinoma (Carcinomatosis) 05/2008
1	Hodgkin Disease (Hodgkin's Disease) 03/2008
1	Melanoma (Melanoma, Malignant) 03/2008
1	Anemia 10/2007
1	Hypotension (Low Blood Pressure) 10/2007
1	Body Weight (Weight, Body) 10/2007
1	Hypocalcemia 10/2007
1	Catheter-Related Infections 10/2007
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2007
1	Inflammation (Inflammations) 09/2007
1	Pancreatitis 03/2007
1	Glioblastoma (Glioblastoma Multiforme) 01/2007

Drug/Important Bio-Agent (IBA)

6	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 11/2002
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2010 - 03/2002
3	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 04/2008
3	Carboplatin (JM8)FDA LinkGeneric 07/2009 - 01/2002
3	TeaIBA 09/2007 - 11/2003
3	Folic Acid (Vitamin M)FDA LinkGeneric 08/2006 - 01/2004
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 07/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013 - 01/2004
2	Asparaginase (Elspar)FDA Link 11/2011 - 03/2007
2	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2009 - 04/2008
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2009 - 11/2006
2	Dexrazoxane (Zinecard)FDA LinkGeneric 03/2008 - 07/2004
2	Matrix Metalloproteinases (MMPs)IBA 09/2007 - 08/2005
2	PolyphenolsIBA 09/2007 - 11/2003
2	delphinidinIBA 01/2007 - 05/2006
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	Leucovorin (Folinic Acid)FDA Link 12/2023
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	Docetaxel (Taxotere)FDA Link 12/2023
1	Diphosphonates (Bisphosphonates)IBA 05/2013
1	Pamidronate (Aredia)FDA LinkGeneric 05/2013
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 11/2011
1	Transcription Factors (Transcription Factor)IBA 11/2011
1	von Willebrand FactorIBA 07/2010
1	SteroidsIBA 07/2010
1	Thrombin FDA Link 07/2010
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 04/2010
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 12/2009
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2009
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 12/2009
1	Tumor Suppressor Protein p53IBA 12/2009
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2009
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 08/2009
1	Multidrug Resistance-Associated ProteinsIBA 08/2009
1	N-cyclopropyl adenosine-5'-carboxamide (CPCA)IBA 07/2009
1	Voriconazole (Vfend)FDA LinkGeneric 03/2008
1	AnthracyclinesIBA 03/2008
1	Hemoglobins (Hemoglobin)IBA 10/2007
1	gamma-Glutamyl Hydrolase (Carboxypeptidase G2)IBA 07/2007
1	Cyclin D1IBA 03/2007
1	Cyclin D3IBA 03/2007
1	petunidinIBA 01/2007
1	PlasminogenIBA 01/2007
1	Anthocyanins (Anthocyanin)IBA 01/2007
1	cyanidinIBA 01/2007
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2006
1	Vinblastine (Vinblastine Sulfate)FDA Link 11/2006
1	Biomarkers (Surrogate Marker)IBA 11/2006
1	Cell Adhesion MoleculesIBA 11/2006

Therapy/Procedure

17	Therapeutics 12/2023 - 01/2002
8	Drug Therapy (Chemotherapy) 12/2023 - 01/2002
2	Radiotherapy 01/2017 - 07/2009
1	Esophagectomy 12/2023
1	Neoadjuvant Therapy 12/2023
1	Adjuvant Chemotherapy 01/2017
1	Oral Administration 05/2008
1	Blood Component Removal (Apheresis) 10/2007
1	Critical Care (Surgical Intensive Care) 10/2007
1	Catheters 10/2007